Priapism after transurethral alprostadil

British Journal of Urology

Volumn 81, Issue 6, 1998, Pages 926-

  Bettocchi, C ^a   Ashford, L ^b   Pryor, J P ^a   Ralph, D J ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PAPAVERINE; PROSTAGLANDIN E1;

ADULT; ARTICLE; BATH; CASE REPORT; HUMAN; INTRACAVERNOUS DRUG ADMINISTRATION; INTRAURETHRAL DRUG ADMINISTRATION; MALE; MALE SEXUAL DYSFUNCTION; PENIS ERECTION; PRIAPISM; PRIORITY JOURNAL;

ALPROSTADIL; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PRIAPISM; VASODILATOR AGENTS;

EID: 0031810024     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1998.00664.x     Document Type: Article

References (2)

1. Linet OI, Ogring FG, for the Alprostadil Study Group. Efficacy and safety of intracavernosal Alprostadil in men with erectile dysfunction. New Eng J Med 1996: 334: 873-7
2. Padma-Nathan H. Hellstrom WJG, Kaiser FE et al. for the Medicated Urethral System for Erection (MUSE) Study Group. Treatment of men with erectile dysfunction with transurethral Alprostadil. New Eng }Med 1997; 336: 1-7